Tue, January 14, 2025
Mon, January 13, 2025
[ Mon, Jan 13th ]: CNET
Rocket Money Review 2025
[ Mon, Jan 13th ]: CFO
A CFO action plan for 2025
Sun, January 12, 2025
Sat, January 11, 2025
Fri, January 10, 2025
Thu, January 9, 2025
Wed, January 8, 2025
Tue, January 7, 2025
Mon, January 6, 2025
Sun, January 5, 2025
Sat, January 4, 2025
Fri, January 3, 2025

J&J pauses US rollout of Varipulse heart device after stroke reports

  Copy link into your clipboard //business-finance.news-articles.net/content/202 .. varipulse-heart-device-after-stroke-reports.html
  Print publication without navigation Published in Business and Finance on by Reuters
          🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source
  Johnson & Johnson said on Wednesday it has temporarily paused the rollout of its Varipulse heart device in the United States, citing an abundance of caution as the company investigates four reported stroke events.

Johnson & Johnson has decided to temporarily halt the rollout of its new heart device in the U.S. to investigate potential risks of stroke associated with its use. This decision comes after the company identified a higher than expected rate of strokes in patients who received the device during clinical trials. The device in question is designed to treat atrial fibrillation, a common heart rhythm disorder. J&J is working closely with the U.S. Food and Drug Administration (FDA) to assess the data and determine the next steps. The company emphasized that patient safety is their top priority and they are committed to ensuring the device's safety before resuming its distribution.

Read the Full Reuters Article at:
[ https://www.reuters.com/business/healthcare-pharmaceuticals/jj-pauses-rollout-heart-device-us-investigate-stroke-risk-2025-01-08/ ]